Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutian Zou

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Cell Biochemistry and Function|January 4, 2019
The PROTAC technology in drug developmentYutian Zou, Danhui Ma, Yinyin Wang
BMC Neurology|January 15, 2022
Distribution of risk factors of ischemic stroke in Chinese young adults and its correlation with prognosisXiaoke Wu, Yutian Zou, Shoujiang You, et al.
Cancers|January 8, 2023
Is Acupuncture an Ideal Adjunctive Treatment for Cancer-Related Fatigue? Comment on Choi et al. Acupuncture for Managing Cancer-Related Fatigue in Breast Cancer Patients: A Systematic Review and Meta-Analysis. <i>Cancers</i> 2022, <i>14</i>, 4419Xiaoqian Hu, Beibei Feng, Jindong Xie, et al.
Journal for Immunotherapy of Cancer|April 2, 2026
Targeting the neuro-immune crosstalk in breast cancer brain metastasesYutian Zou, Jiadi Wu, Ze Yuan, et al.
Medical Review (2021)|July 2, 2025
Histone lactylation as a driver of metabolic reprogramming and immune evasionQiaoting Cai, Wei Deng, Yutian Zou, et al.
Cancer Gene Therapy|October 29, 2025
Disulfidptosis in cancer: from redox stress to therapeutic strategyXinpei Deng, Chengyi Zhang, Jindong Xie, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 2, 2022
Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2-Positive Breast CancerJindong Xie, Yutian Zou, Ting Gao, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 12, 2020
[Gly14]-humanin restores cathepsin D function via FPRL1 and promotes autophagic degradation of Ox-LDL in HUVECsYu Ding, Yue Feng, Yutian Zou, et al.
Frontiers in Immunology|November 29, 2023
Recent advances in exosome-based immunotherapy applied to cancerJindong Xie, Zihan Zheng, Ling Tuo, et al.
Aging|December 21, 2019
CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1Weikai Xiao, Shaoquan Zheng, Yutian Zou, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Cell Biochemistry and Function|January 4, 2019
The PROTAC technology in drug developmentYutian Zou, Danhui Ma, Yinyin Wang
BMC Neurology|January 15, 2022
Distribution of risk factors of ischemic stroke in Chinese young adults and its correlation with prognosisXiaoke Wu, Yutian Zou, Shoujiang You, et al.
Cancers|January 8, 2023
Is Acupuncture an Ideal Adjunctive Treatment for Cancer-Related Fatigue? Comment on Choi et al. Acupuncture for Managing Cancer-Related Fatigue in Breast Cancer Patients: A Systematic Review and Meta-Analysis. <i>Cancers</i> 2022, <i>14</i>, 4419Xiaoqian Hu, Beibei Feng, Jindong Xie, et al.
Journal for Immunotherapy of Cancer|April 2, 2026
Targeting the neuro-immune crosstalk in breast cancer brain metastasesYutian Zou, Jiadi Wu, Ze Yuan, et al.
Medical Review (2021)|July 2, 2025
Histone lactylation as a driver of metabolic reprogramming and immune evasionQiaoting Cai, Wei Deng, Yutian Zou, et al.
Cancer Gene Therapy|October 29, 2025
Disulfidptosis in cancer: from redox stress to therapeutic strategyXinpei Deng, Chengyi Zhang, Jindong Xie, et al.
Cancer Control : Journal of the Moffitt Cancer Center|May 2, 2022
Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2-Positive Breast CancerJindong Xie, Yutian Zou, Ting Gao, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 12, 2020
[Gly14]-humanin restores cathepsin D function via FPRL1 and promotes autophagic degradation of Ox-LDL in HUVECsYu Ding, Yue Feng, Yutian Zou, et al.
Frontiers in Immunology|November 29, 2023
Recent advances in exosome-based immunotherapy applied to cancerJindong Xie, Zihan Zheng, Ling Tuo, et al.
Aging|December 21, 2019
CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1Weikai Xiao, Shaoquan Zheng, Yutian Zou, et al.
Pageof 8